Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Hepatoblastoma surveillance in infants born with very low birth weight: Has the time come?

Hadžić N, Cho SJ, Finegold MJ.

J Pediatr. 2019 Oct 9. pii: S0022-3476(19)31156-4. doi: 10.1016/j.jpeds.2019.09.020. [Epub ahead of print] No abstract available.

PMID:
31606153
2.

Sox9 is a modifier of the liver disease severity in a mouse model of Alagille syndrome.

Adams JM, Huppert KA, Castro EC, Lopez MF, Niknejad N, Subramanian S, Zarrin-Khameh N, Finegold MJ, Huppert SS, Jafar-Nejad H.

Hepatology. 2019 Aug 30. doi: 10.1002/hep.30912. [Epub ahead of print]

PMID:
31469182
3.

Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the Children's Oncology Group AHEP 0731 Liver Tumor Committee.

Weldon CB, Madenci AL, Tiao GM, Dunn SP, Langham MR, McGahren ED, Ranganathan S, López-Terrada DH, Finegold MJ, Malogolowkin MH, Piao J, Huang L, Krailo MD, Meyers RL, Katzenstein HM.

J Pediatr Surg. 2019 May 11. pii: S0022-3468(19)30347-1. doi: 10.1016/j.jpedsurg.2019.05.004. [Epub ahead of print]

PMID:
31126688
4.

Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation.

Haines K, Sarabia SF, Alvarez KR, Tomlinson G, Vasudevan SA, Heczey AA, Roy A, Finegold MJ, Parsons DW, Plon SE, López-Terrada D.

Pediatr Blood Cancer. 2019 Jul;66(7):e27745. doi: 10.1002/pbc.27745. Epub 2019 Apr 11.

PMID:
30977242
5.

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.

Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, Finegold MJ, Ranganathan S, Dunn S, McGahren ED, Tiao GM, O'Neill AF, Qayed M, Furman WL, Xia C, Rodriguez-Galindo C, Meyers RL.

Lancet Oncol. 2019 May;20(5):719-727. doi: 10.1016/S1470-2045(18)30895-7. Epub 2019 Apr 8. Erratum in: Lancet Oncol. 2019 May;20(5):e243.

PMID:
30975630
6.

Identification of Polycystic Kidney Disease 1 Like 1 Gene Variants in Children With Biliary Atresia Splenic Malformation Syndrome.

Berauer JP, Mezina AI, Okou DT, Sabo A, Muzny DM, Gibbs RA, Hegde MR, Chopra P, Cutler DJ, Perlmutter DH, Bull LN, Thompson RJ, Loomes KM, Spinner NB, Rajagopalan R, Guthery SL, Moore B, Yandell M, Harpavat S, Magee JC, Kamath BM, Molleston JP, Bezerra JA, Murray KF, Alonso EM, Rosenthal P, Squires RH, Wang KS, Finegold MJ, Russo P, Sherker AH, Sokol RJ, Karpen SJ; Childhood Liver Disease Research Network (ChiLDReN).

Hepatology. 2019 Sep;70(3):899-910. doi: 10.1002/hep.30515. Epub 2019 Mar 21.

PMID:
30664273
7.

Growth Factor-Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer.

Chen MS, Lo YH, Chen X, Williams CS, Donnelly JM, Criss ZK 2nd, Patel S, Butkus JM, Dubrulle J, Finegold MJ, Shroyer NF.

Mol Cancer Res. 2019 Mar;17(3):697-708. doi: 10.1158/1541-7786.MCR-18-0666. Epub 2019 Jan 3.

PMID:
30606770
8.

Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.

Kodama T, Yi J, Newberg JY, Tien JC, Wu H, Finegold MJ, Kodama M, Wei Z, Tamura T, Takehara T, Johnson RL, Jenkins NA, Copeland NG.

Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):E10417-E10426. doi: 10.1073/pnas.1808968115. Epub 2018 Oct 16.

9.

Inflammation, Active Fibroplasia, and End-stage Fibrosis in 172 Biliary Atresia Remnants Correlate Poorly With Age at Kasai Portoenterostomy, Visceral Heterotaxy, and Outcome.

Bove KE, Thrasher AD, Anders R, Chung CT, Cummings OW, Finegold MJ, Finn L, Ranganathan S, Kim GE, Lovell M, Magid MS, Melin-Aldana H, Russo P, Shehata B, Wang L, White F, Chen Z, Spino C, Magee JC.

Am J Surg Pathol. 2018 Dec;42(12):1625-1635. doi: 10.1097/PAS.0000000000001146.

10.

Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis.

Kim KH, Choi JM, Li F, Arizpe A, Wooton-Kee CR, Anakk S, Jung SY, Finegold MJ, Moore DD.

Endocrinology. 2018 Jun 1;159(6):2435-2446. doi: 10.1210/en.2018-00110.

PMID:
29718219
11.

Factors Influencing Time-to-diagnosis of Biliary Atresia.

Harpavat S, Lupo PJ, Liwanag L, Hollier J, Brandt ML, Finegold MJ, Shneider BL.

J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):850-856. doi: 10.1097/MPG.0000000000001887.

12.

Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.

Lu L, Finegold MJ, Johnson RL.

Exp Mol Med. 2018 Jan 5;50(1):e423. doi: 10.1038/emm.2017.205.

13.

Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.

O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR Jr, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, Malogolowkin M, Rodriguez-Galindo C, Katzenstein HM.

J Clin Oncol. 2017 Oct 20;35(30):3465-3473. doi: 10.1200/JCO.2017.73.5654. Epub 2017 Sep 11.

14.

A Rare Phenotype of Alpha-1-Antitrypsin Deficiency Owing to PI*IS in a Newborn With Liver Disease.

Huang AC, Perez C, Felipez L, Chamyan G, Finegold MJ, Hernandez E.

J Pediatr Gastroenterol Nutr. 2017 Nov;65(5):e112-e113. doi: 10.1097/MPG.0000000000001716. No abstract available.

PMID:
28837509
15.

Contemporary Evaluation of the Pediatric Liver Biopsy.

Schady DA, Finegold MJ.

Gastroenterol Clin North Am. 2017 Jun;46(2):233-252. doi: 10.1016/j.gtc.2017.01.013. Review.

PMID:
28506363
16.

Hepatic Hilar Lymph Node Reactivity at Kasai Portoenterostomy for Biliary Atresia: Correlations With Age, Outcome, and Histology of Proximal Biliary Remnant.

Bove KE, Sheridan R, Fei L, Anders R, Chung CT, Cummings OW, Finegold MJ, Finn L, Ranganathan S, Kim G, Lovell M, Magid MS, Melin-Aldana H, Russo P, Shehata B, Wang L, White F, Chen Z, Spino C, Magee JC.

Pediatr Dev Pathol. 2018 Jan-Feb;21(1):29-40. doi: 10.1177/1093526617707851. Epub 2017 May 5.

PMID:
28474973
17.

Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.

Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ, Tiao GM, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Rodriguez-Galindo C, Meyers RL.

Cancer. 2017 Jun 15;123(12):2360-2367. doi: 10.1002/cncr.30591. Epub 2017 Feb 17.

18.

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Kettner NM, Voicu H, Finegold MJ, Coarfa C, Sreekumar A, Putluri N, Katchy CA, Lee C, Moore DD, Fu L.

Cancer Cell. 2016 Dec 12;30(6):909-924. doi: 10.1016/j.ccell.2016.10.007. Epub 2016 Nov 23.

19.

Pathology of the liver in children: Where would I (we) be without "Pepper"?

Finegold MJ.

Semin Diagn Pathol. 2016 Nov;33(6):367-376. doi: 10.1053/j.semdp.2016.08.002. Epub 2016 Sep 4.

PMID:
27793410
20.

Key Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A Multicenter Study.

Russo P, Magee JC, Anders RA, Bove KE, Chung C, Cummings OW, Finegold MJ, Finn LS, Kim GE, Lovell MA, Magid MS, Melin-Aldana H, Ranganathan S, Shehata BM, Wang LL, White FV, Chen Z, Spino C; Childhood Liver Disease Research Network (ChiLDReN).

Am J Surg Pathol. 2016 Dec;40(12):1601-1615.

21.

Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.

Sumazin P, Chen Y, Treviño LR, Sarabia SF, Hampton OA, Patel K, Mistretta TA, Zorman B, Thompson P, Heczey A, Comerford S, Wheeler DA, Chintagumpala M, Meyers R, Rakheja D, Finegold MJ, Tomlinson G, Parsons DW, López-Terrada D.

Hepatology. 2017 Jan;65(1):104-121. doi: 10.1002/hep.28888. Epub 2016 Nov 29.

PMID:
27775819
22.

Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Comerford SA, Hinnant EA, Chen Y, Bansal H, Klapproth S, Rakheja D, Finegold MJ, Lopez-Terrada D, O'Donnell KA, Tomlinson GE, Hammer RE.

JCI Insight. 2016 Oct 6;1(16):e88549. doi: 10.1172/jci.insight.88549.

23.

The mucosal microbiota in a young child with severe non-Helicobacter gastritis.

Preidis GA, Luna RA, Hollister EB, Schady D, Gao C, Finegold MJ, Versalovic J, Shulman RJ.

Therap Adv Gastroenterol. 2016 Sep;9(5):749-51. doi: 10.1177/1756283X16653582. Epub 2016 Jun 14. No abstract available.

24.

Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients.

Karandikar UC, Crawford SE, Ajami NJ, Murakami K, Kou B, Ettayebi K, Papanicolaou GA, Jongwutiwes U, Perales MA, Shia J, Mercer D, Finegold MJ, Vinjé J, Atmar RL, Estes MK.

J Gen Virol. 2016 Sep;97(9):2291-2300. doi: 10.1099/jgv.0.000545. Epub 2016 Jul 12.

25.

Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.

Kodama T, Newberg JY, Kodama M, Rangel R, Yoshihara K, Tien JC, Parsons PH, Wu H, Finegold MJ, Copeland NG, Jenkins NA.

Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3384-93. doi: 10.1073/pnas.1606876113. Epub 2016 May 31.

26.

Hepatoblastoma Arising in a Pigmented β-catenin-activated Hepatocellular Adenoma: Case Report and Review of the Literature.

Louie CY, Concepcion W, Park JK, Rangaswami A, Finegold MJ, Hazard FK.

Am J Surg Pathol. 2016 Jul;40(7):998-1003. doi: 10.1097/PAS.0000000000000652. Review.

PMID:
27096257
27.

Undifferentiated Embryonal Sarcoma of the Liver (UESL): A Single-Center Experience and Review of the Literature.

Techavichit P, Masand PM, Himes RW, Abbas R, Goss JA, Vasudevan SA, Finegold MJ, Heczey A.

J Pediatr Hematol Oncol. 2016 May;38(4):261-8. doi: 10.1097/MPH.0000000000000529. Review.

PMID:
26925712
28.

A Case of an 11-year-old With Cough, Diarrhea, and Findings of Concern in His Lungs and Spleen.

Darby JB, Rees CA, Bocchini CE, Cruz AT, Kellermayer R, Finegold MJ, Barlow SE.

Pediatrics. 2016 Mar;137(3):e20150155. doi: 10.1542/peds.2015-0155. Epub 2016 Feb 15.

29.

Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.

Gomez-Ospina N, Potter CJ, Xiao R, Manickam K, Kim MS, Kim KH, Shneider BL, Picarsic JL, Jacobson TA, Zhang J, He W, Liu P, Knisely AS, Finegold MJ, Muzny DM, Boerwinkle E, Lupski JR, Plon SE, Gibbs RA, Eng CM, Yang Y, Washington GC, Porteus MH, Berquist WE, Kambham N, Singh RJ, Xia F, Enns GM, Moore DD.

Nat Commun. 2016 Feb 18;7:10713. doi: 10.1038/ncomms10713.

30.

Liver tumors in children with metabolic disorders.

Schady DA, Roy A, Finegold MJ.

Transl Pediatr. 2015 Oct;4(4):290-303. doi: 10.3978/j.issn.2224-4336.2015.10.08. Review.

31.

TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.

Chen J, Yao ZX, Chen JS, Gi YJ, Muñoz NM, Kundra S, Herlong HF, Jeong YS, Goltsov A, Ohshiro K, Mistry NA, Zhang J, Su X, Choufani S, Mitra A, Li S, Mishra B, White J, Rashid A, Wang AY, Javle M, Davila M, Michaely P, Weksberg R, Hofstetter WL, Finegold MJ, Shay JW, Machida K, Tsukamoto H, Mishra L.

J Clin Invest. 2016 Feb;126(2):527-42. doi: 10.1172/JCI80937. Epub 2016 Jan 19.

32.

Newborn Direct or Conjugated Bilirubin Measurements As a Potential Screen for Biliary Atresia.

Harpavat S, Ramraj R, Finegold MJ, Brandt ML, Hertel PM, Fallon SC, Shepherd RW, Shneider BL.

J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):799-803. doi: 10.1097/MPG.0000000000001097.

PMID:
26720765
33.

P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients.

Maynard JP, Lee JS, Sohn BH, Yu X, Lopez-Terrada D, Finegold MJ, Goss JA, Thevananther S.

Oncotarget. 2015 Dec 1;6(38):41162-79. doi: 10.18632/oncotarget.6240.

34.

Elevated copper impairs hepatic nuclear receptor function in Wilson's disease.

Wooton-Kee CR, Jain AK, Wagner M, Grusak MA, Finegold MJ, Lutsenko S, Moore DD.

J Clin Invest. 2015 Sep;125(9):3449-60. doi: 10.1172/JCI78991. Epub 2015 Aug 4.

35.

Hepatocellular carcinoma associated with tight-junction protein 2 deficiency.

Zhou S, Hertel PM, Finegold MJ, Wang L, Kerkar N, Wang J, Wong LJ, Plon SE, Sambrotta M, Foskett P, Niu Z, Thompson RJ, Knisely AS.

Hepatology. 2015 Dec;62(6):1914-6. doi: 10.1002/hep.27872. Epub 2015 Jun 19. No abstract available.

36.

Focal nodular hyperplasia in children: an institutional experience with review of the literature.

Ma IT, Rojas Y, Masand PM, Castro EC, Himes RW, Kim ES, Goss JA, Nuchtern JG, Finegold MJ, Thompson PA, Vasudevan SA.

J Pediatr Surg. 2015 Mar;50(3):382-7. doi: 10.1016/j.jpedsurg.2014.06.016. Epub 2014 Aug 27. Review.

PMID:
25746693
37.

Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis.

Dong B, Lee JS, Park YY, Yang F, Xu G, Huang W, Finegold MJ, Moore DD.

Nat Commun. 2015 Feb 9;6:5944. doi: 10.1038/ncomms6944.

38.

An infant with persistent jaundice and a normal newborn direct bilirubin measurement.

Harpavat S, Devaraj S, Finegold MJ.

Clin Chem. 2015 Feb;61(2):330-3. doi: 10.1373/clinchem.2014.223115. No abstract available.

39.

Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes.

Tarlow BD, Pelz C, Naugler WE, Wakefield L, Wilson EM, Finegold MJ, Grompe M.

Cell Stem Cell. 2014 Nov 6;15(5):605-18. doi: 10.1016/j.stem.2014.09.008. Epub 2014 Oct 9.

40.

The organoid-initiating cells in mouse pancreas and liver are phenotypically and functionally similar.

Dorrell C, Tarlow B, Wang Y, Canaday PS, Haft A, Schug J, Streeter PR, Finegold MJ, Shenje LT, Kaestner KH, Grompe M.

Stem Cell Res. 2014 Sep;13(2):275-83. doi: 10.1016/j.scr.2014.07.006. Epub 2014 Jul 27.

41.

CT, MRI, and 18F-FDG PET/CT in a patient with nested stromal epithelial tumor of the liver.

Samarghandi A, Barker DW, Hingsbergen EA, Finegold MJ, Hall NC.

Clin Nucl Med. 2015 Feb;40(2):131-3. doi: 10.1097/RLU.0000000000000542.

PMID:
25140542
42.

Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease.

Hickey RD, Mao SA, Glorioso J, Lillegard JB, Fisher JE, Amiot B, Rinaldo P, Harding CO, Marler R, Finegold MJ, Grompe M, Nyberg SL.

Stem Cell Res. 2014 Jul;13(1):144-53. doi: 10.1016/j.scr.2014.05.003. Epub 2014 May 14.

43.

β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.

Mokkapati S, Niopek K, Huang L, Cunniff KJ, Ruteshouser EC, deCaestecker M, Finegold MJ, Huff V.

Cancer Res. 2014 Aug 15;74(16):4515-25. doi: 10.1158/0008-5472.CAN-13-3275. Epub 2014 May 21.

44.

Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury.

Tarlow BD, Finegold MJ, Grompe M.

Hepatology. 2014 Jul;60(1):278-89. doi: 10.1002/hep.27084. Epub 2014 May 28.

45.

Bile acids activate YAP to promote liver carcinogenesis.

Anakk S, Bhosale M, Schmidt VA, Johnson RL, Finegold MJ, Moore DD.

Cell Rep. 2013 Nov 27;5(4):1060-9. doi: 10.1016/j.celrep.2013.10.030. Epub 2013 Nov 21.

46.

Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium.

López-Terrada D, Alaggio R, de Dávila MT, Czauderna P, Hiyama E, Katzenstein H, Leuschner I, Malogolowkin M, Meyers R, Ranganathan S, Tanaka Y, Tomlinson G, Fabrè M, Zimmermann A, Finegold MJ; Children's Oncology Group Liver Tumor Committee.

Mod Pathol. 2014 Mar;27(3):472-91. doi: 10.1038/modpathol.2013.80. Epub 2013 Sep 6.

47.

A novel role of nucleostemin in maintaining the genome integrity of dividing hepatocytes during mouse liver development and regeneration.

Lin T, Ibrahim W, Peng CY, Finegold MJ, Tsai RY.

Hepatology. 2013 Dec;58(6):2176-87. doi: 10.1002/hep.26600. Epub 2013 Oct 21.

48.

In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration.

Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, Sato T, Hamer K, Sasaki N, Finegold MJ, Haft A, Vries RG, Grompe M, Clevers H.

Nature. 2013 Feb 14;494(7436):247-50. doi: 10.1038/nature11826. Epub 2013 Jan 27.

49.

Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment.

Rogosnitzky M, Finegold MJ, McLaughlin PJ, Zagon IS.

Invest New Drugs. 2013 Aug;31(4):1066-70. doi: 10.1007/s10637-012-9918-3. Epub 2012 Dec 30.

PMID:
23275062
50.

Does short bowel syndrome increase the risk of food allergy and eosinophilic gastrointestinal disease? Observations in Shah-Waardenburg syndrome.

Leechawengwongs E, Tison BE, Gopalakrishna GS, Reid BS, Bacino CA, Haws AL, Finegold MJ, Shearer WT.

J Allergy Clin Immunol. 2013 Jan;131(1):251-5. doi: 10.1016/j.jaci.2012.08.053. Epub 2012 Nov 21. No abstract available.

PMID:
23177999

Supplemental Content

Loading ...
Support Center